In vitiligo, melanocytes show poor antioxidant capacity due to alterations in antioxidant mechanisms, such as AHR and NRF2/ heme oxygenase-1(HO-1) system, which result in high levels of superoxide dismutase and low levels of catalase [78]. The gene discussed is HMOX1; the disease is vitiligo.